UCSF has launched the Alzheimer's Tau Platform (ATP) trial, the first large-scale clinical trial testing combination therapies that target both amyloid plaques and tau tangles simultaneously.

Testing costs too much and takes too long. Guilty. The Army Test and Evaluation Command (ATEC) is committed to doing better.

Stool‑based microbiome testing is widely used in integrative medicine, but it provides only a distal luminal snapshot, not the full gut ecology ...

NVIDIA (NASDAQ:NVDA) told investors to expect $91.0 billion in revenue for the second quarter of fiscal 2027, plus or minus 2 ...

Northrop Grumman Q2 2026 earnings preview; expectations, key risks, fundamentals and NOC valuation after pullback. Read why ...

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.

With RGB lighting and easy access to the internal slot, Asus’s Aiolos 20Gbps NVMe enclosure is a top choice for gamers.

AI engines now decide which brands to recommend, trust, and transact with. Learn the six steps to become AI's preferred ...

The Novig promo code unlocks a mathematically sound starting point exclusively for new users exploring the platform. By ...

GPT-5.6 Sol, Terra, and Luna are now broadly available after 12 days in a government-gated preview that exposed OpenAI’s ...

DeepSeek speculative decoding framework DSpark went live June 27 on V4-Flash and V4-Pro, reporting up to 85 percent faster ...